10

WATCH NOW

Myeloma: The new playbook

BRISTOL MYERS SQUIBB

R & D PIPELINE SIZE: 158 EMPLOYEES: 32,500 CHIEF DIGITAL & TECHNOLOGY OFFICER: GREG MEYERS

Bristol Myers Squibb( BMS) is a New Jersey-headquartered pharmaceutical firm long associated with immunooncology and oncology candidates. Its pipeline includes established franchises such as Opdivo, Yervoy, Eliquis and Revlimid. Cobenfy, a novel Schizophrenia drug is being tested as a treatment for Alzheimer’ s psychosis in Phase 3 trials, while continued oncology coverage remains key to its pipeline following acquisitions of Celgene and Mirati. An immunology push via cell therapy deals has also been a core strand of its pipeline strategy.

CREDIT: BRISTOL MYERS SQUIBB

34 October 2026